Evidence map›Paper›PMID 27465719›Full record

ArticleScientific reports2016

Cell-free methods to produce structurally intact mammalian membrane proteins.

Takehiro Shinoda, Naoko Shinya, Kaori Ito, Yoshiko Ishizuka-Katsura, Noboru Ohsawa, Takaho Terada, Kunio Hirata, Yoshiaki Kawano, Masaki Yamamoto, Taisuke Tomita and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Human Claudin-7Frontiers in molecular biosciences · 2022
    Article
  16. Cell-Free Membrane Protein Expression into Hybrid Lipid/Polymer Vesicles.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  17. Article
  18. Article
  19. Engineering spatiotemporal organization and dynamics in synthetic cells.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2021
    Review
  20. Structural basis forProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Takehiro ShinodaRIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Naoko ShinyaRIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Kaori ItoRIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Yoshiko Ishizuka-KatsuraRIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Noboru OhsawaRIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Takaho TeradaRIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Kunio HirataRIKEN SPring-8 Center, 1-1-1, Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5148, Japan.
Yoshiaki KawanoRIKEN SPring-8 Center, 1-1-1, Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5148, Japan.
Masaki YamamotoRIKEN SPring-8 Center, 1-1-1, Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5148, Japan.
Taisuke TomitaDepartment of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
Yohei IshibashiLaboratory for Molecular Membrane Neuroscience, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
Yoshio HirabayashiLaboratory for Molecular Membrane Neuroscience, RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
Tomomi Kimura-SomeyaRIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Mikako ShirouzuRIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Shigeyuki YokoyamaRIKEN Systems and Structural Biology Center, Yokohama 230-0045, Japan.
Systems Biology Institute · JPSPring-8 · JPRIKEN Center for Brain Science · JPRIKEN · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The crystal structures of four membrane proteins, from bacteria or a unicellular alga, have been solved with samples produced by cell-free protein synthesis. In this study, for mammalian membrane protein production, we established the precipitating and soluble membrane fragment methods: membrane proteins are synthesized with the Escherichia coli cell-free system in the presence of large and small membrane fragments, respectively, and are simultaneously integrated into the lipid environments. We applied the precipitating membrane fragment method to produce various mammalian membrane proteins, including human claudins, glucosylceramide synthase, and the γ-secretase subunits. These proteins were produced at levels of about 0.1-1.0 mg per ml cell-free reaction under the initial conditions, and were obtained as precipitates by ultracentrifugation. Larger amounts of membrane proteins were produced by the soluble membrane fragment method, collected in the ultracentrifugation supernatants, and purified directly by column chromatography. For several proteins, the conditions of the membrane fragment methods were further optimized, such as by the addition of specific lipids/detergents. The functional and structural integrities of the purified proteins were confirmed by analyses of their ligand binding activities, size-exclusion chromatography profiles, and/or thermal stabilities. We successfully obtained high-quality crystals of the complex of human claudin-4 with an enterotoxin.

Indexed as

Amyloid Precursor Protein SecretasesAnimalsCell-Free SystemCell MembraneChemical PrecipitationClaudin-4Crystallography, X-RayEnterotoxinsGlucosyltransferasesHumansLipidsMammalsMembrane ProteinsProtein SubunitsSolubilitySubcellular FractionsAmyloid Precursor Protein Secretasesceramide glucosyltransferaseClaudin-4enterotoxin, ClostridiumEnterotoxinsGlucosyltransferasesLipidsMembrane ProteinsProtein Subunits

Identifiers

PMID27465719
PMCPMC4964339
OpenAlexW2494911024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.